Genetic mutation test kit GD-QCY-0014

for acute myeloid leukemiafor IDH2 mutationsmyeloid leukemia

Product overview
The GD-QCY-0014 PCR kit provides specific detection of IDH2 gene mutations associated with acute myeloid leukemia (AML). It is designed for use in clinical molecular diagnostics and research workflows to support diagnosis and therapeutic decision-making.

Application
Intended for accurate identification of IDH2 mutations in AML patient specimens. Suitable for analysis of whole blood and bone marrow samples to guide targeted treatment selection.

Key product information
Product Name: Acute Myeloid Leukemia IDH2 Mutation Test PCR Kit
Catalog No.: GD-QCY-0014
Description: PCR kit for specific detection of IDH2 gene mutations to support AML diagnosis and therapy guidance.
Application: Detection of IDH2 mutations in acute myeloid leukemia (AML).
Certification: FDA
Target Disease: Acute myeloid leukemia
Detection Target: IDH2
Assay Type: PCR
Samples: Blood and bone marrow
Test Time: 48 h
Storage: Store at 2-8°C and protect from light.
Specification / Quantity: 96T

Notes
For in vitro diagnostic use. Use by qualified laboratory personnel and follow local regulatory requirements.

Technical specifications

• Detection target: IDH2 gene mutations
• Intended use: Detection and guidance for targeted treatment in acute myeloid leukemia (AML)
• Assay format: PCR-based assay
• Sample types: Whole blood and bone marrow specimens
• Turnaround / test time: Approximately 48 hours
• Storage conditions: 2-8°C, protect from light
• Certification status: FDA
• Pack size / format available: 96T (96 tests)